Which action is NOT typically part of responding to a drug recall notice?

Prepare for the Pharmacology Hospital Unit Clerk Test with flashcards and multiple choice questions. Each question comes with hints and explanations to help you succeed. Ace your exam!

Multiple Choice

Which action is NOT typically part of responding to a drug recall notice?

Explanation:
The action being tested is how to respond safely to a drug recall. When a recall notice goes out, the priority is to stop exposure to the recalled product and prevent further administration. That means quickly removing the affected stock from distribution, then quarantining it and documenting the lot numbers so you can trace exactly which doses and patients might be affected. It also requires notifying the nursing staff and pharmacy so everyone handling medications is aware and can implement the hold, substitution, or return processes as directed. Updating the patient medication record to continue using the recalled stock would undermine the safety goal of a recall. Instead, the MAR should reflect that the item is on hold or recalled, with instructions to discontinue use or substitute a safe alternative if available. This ensures clinicians do not administer a drug that has been flagged as unsafe.

The action being tested is how to respond safely to a drug recall. When a recall notice goes out, the priority is to stop exposure to the recalled product and prevent further administration. That means quickly removing the affected stock from distribution, then quarantining it and documenting the lot numbers so you can trace exactly which doses and patients might be affected. It also requires notifying the nursing staff and pharmacy so everyone handling medications is aware and can implement the hold, substitution, or return processes as directed.

Updating the patient medication record to continue using the recalled stock would undermine the safety goal of a recall. Instead, the MAR should reflect that the item is on hold or recalled, with instructions to discontinue use or substitute a safe alternative if available. This ensures clinicians do not administer a drug that has been flagged as unsafe.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy